 |
4-pyridinylmethyl 3(4-chlorophenyl)adamantine carboxamide |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-11-02 00:00:00 |
| Sponsor | Apogee Biotechnology Corporation;Hershey Center for Applied Research, Suite 1016;Hummelstown, Pennsylvania, 17036 |
